secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001193125-26-057707
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo shareholders approve issuance of >19.99% of common stock to Yorkville
----------------------------------------------------------------------------

- Shareholders approved issuance of more than 19.99% of outstanding common stock under Standby Equity Purchase Agreement with Yorkville.
- Vote on Proposal 2 (stock issuance): 83,051 for, 29,168 against, 1,816 abstain, 225,099 broker non-votes.
- Proposal 1 (charter amendment for technical changes) not approved: 273,162 for, 61,044 against, 4,928 abstain.
- Proposal 3 (adjournment) approved: 270,356 for, 64,975 against, 3,803 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000119312526057707/0001193125-26-057707-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000119312526057707/apvo-20260218.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-057707

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer